Search

Your search keyword '"Epidermal growth factor receptor"' showing total 1,060 results

Search Constraints

Start Over You searched for: Descriptor "Epidermal growth factor receptor" Remove constraint Descriptor: "Epidermal growth factor receptor" Publication Year Range This year Remove constraint Publication Year Range: This year
1,060 results on '"Epidermal growth factor receptor"'

Search Results

1. Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities.

2. The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions.

3. Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

4. Screening of protein-based inhibitors for the intracellular domain of epidermal growth factor receptor by directed evolution using the yeast Gγ recruitment system.

5. EGFR mutation testing, treatment and survival in stage I–III non-small cell lung cancer: CancerLinQ Discovery database retrospective analysis.

6. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.

7. Amphiregulin promotes activated regulatory T cell-suppressive function via the AREG/EGFR pathway in laryngeal squamous cell carcinoma.

8. Detection of circulating tumor cells in patients with lung cancer using a rare cell sorter: a pilot study.

9. H Antigen expression modulates epidermal Keratinocyte Integrity and differentiation.

10. Atypical Exon 2/3 Mutants G48C, Q43K, and E37K Present Oncogenic Phenotypes Distinct from Characterized NRAS Variants.

11. Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result.

12. Ramucirumab‐induced ascites with endothelial growth factor receptor mutation‐positive non‐small cell lung cancer: Two case reports.

13. Explainable 18F-FDG PET/CT radiomics model for predicting EGFR mutation status in lung adenocarcinoma: a two-center study.

14. 肿瘤坏死因子受体相关因子4促表皮生长 因子受体激酶活性及对肺癌的促进作用.

15. Prevalence and clinical factors associated with survival in patients with EGFR-mutated lung cancer in Argentina.

16. EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma.

17. Successful rapid improvement of acute respiratory distress syndrome induced by EGFR-mutated non-small cell lung cancer with almonertinib: a case report.

18. Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study.

19. EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis.

20. Analysis of clinicopathological characteristics and prognostic factors in 54 metaplastic breast carcinoma patients from northwest China.

21. Intrinsic impacts of the expression of PD-L1 on postoperative recurrence in EGFR-mutated lung adenocarcinoma.

22. GraphEGFR: Multi‐task and transfer learning based on molecular graph attention mechanism and fingerprints improving inhibitor bioactivity prediction for EGFR family proteins on data scarcity.

23. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review.

24. Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.

25. Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance.

26. Amphiregulin promotes activated regulatory T cell-suppressive function via the AREG/EGFR pathway in laryngeal squamous cell carcinoma

27. Detection of circulating tumor cells in patients with lung cancer using a rare cell sorter: a pilot study

28. Epidermal growth factor receptor promotes osteoclast differentiation probably through regulating ABCC1 and CDC37

29. Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result

30. Glioblastoma multiforme - a rare type of cancer: A narrative review

31. Computed tomography‐based radiomics and clinical‐genetic features for brain metastasis prediction in patients with stage III/IV epidermal growth factor receptor‐mutant non‐small‐cell lung cancer

32. Successful rapid improvement of acute respiratory distress syndrome induced by EGFR-mutated non-small cell lung cancer with almonertinib: a case report

33. EGFR Exon 20 Insertion Mutation: Research Status and New Treatment Strategies

34. Advances in Diagnosis and Targeted Therapy of G719X/L861Q/S768I Mutant Non-small Cell Lung Cancer

35. Association between exposure to organophosphate flame retardants and epidermal growth factor receptor expression in lung cancer patients

36. Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer

37. A case of Ph+ acute lymphoblastic leukemia and EGFR mutant lung adenocarcinoma synchronous overlap: may one TKI drug solve two diseases?

38. Epidermal growth factor receptor immuno-expression in malignant epithelial ovarian tumors

39. Inhibition of EGFR attenuates EGF-induced activation of retinal pigment epithelium cell via EGFR/AKT signaling pathway

40. Insights Into Benzothiazolyl‐Coupled Azetidinone Moieties Toward EGFR Binding and Stability Analysis—Evidence From Molecular Docking and Dynamics Simulation.

41. Involvement of HDAC2-mediated kcnq2/kcnq3 genes transcription repression activated by EREG/EGFR-ERK-Runx1 signaling in bone cancer pain.

42. Association between exposure to organophosphate flame retardants and epidermal growth factor receptor expression in lung cancer patients.

43. Yttrium Functionalized Reduced Graphene Oxide Nanocomposite-Based Aptasensor for Ultrasensitive Detection of a Breast Cancer Biomarker.

44. Computed tomography‐based radiomics and clinical‐genetic features for brain metastasis prediction in patients with stage III/IV epidermal growth factor receptor‐mutant non‐small‐cell lung cancer.

45. Amphiregulin Switches Progenitor Cell Fate for Lineage Commitment During Gastric Mucosal Regeneration.

46. 异羟肟酸类化合物对突变型 EGFR 细胞的 生物活性研究.

47. PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients.

48. Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study

49. Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR‐mutated NSCLC with high thrombospondin‐1 expression.

50. Epidermal growth factor receptor and programmed cell death‐1 expression levels in peripheral T cell subsets of patients with non‐small cell lung cancer.

Catalog

Books, media, physical & digital resources